Harvard Medical School geneticists have created a new model-in-a-dish of sporadic Alzheimer’s disease that removes a major obstacle for scientists seeking to pinpoint the causes of sporadic Alzheimer’s and find drugs that might prevent or reverse its devastating neurodegenerative effects.
In a new study, USC researchers used machine learning to identify potential blood-based markers of Alzheimer’s disease that could help with earlier diagnosis and tracking the progress of the disease.
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from Washington University School of Medicine in St. Louis and the German Center for Neurodegenerative Diseases in Germany.
Leaky capillaries in the brain portend early onset of Alzheimer’s disease as they signal cognitive impairment before hallmark toxic proteins appear, new USC research shows.
Researchers at Washington University School of Medicine in St. Louis may have uncovered the reason poor sleep is a hallmark of Alzheimer’s disease.
A new study suggests that tools to diagnose Alzheimer's disease in Caucasian populations may not work as well for African-Americans.
Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s and even restores memories in mice.
A new study has uncovered novel details about the vulnerability of one type of brain cell to Alzheimer’s disease.
A new USC study shows that older African-Americans who received culturally tailored text messages about Alzheimer’s disease had the highest increase in Alzheimer’s disease literacy levels when compared with other participants.
Stiff arteries could lead to “silent” brain damage and therefore dementia risk, a 15-year study led by researchers at Pitt Public Health found. And that risk factor could be preventable.